Cassava Sciences to Present at the H.C. Wainwright Conference
Cassava Sciences, Inc. (Nasdaq: SAVA), an innovative biotechnology company dedicated to tackling Alzheimer's disease, is preparing to showcase its work at the H.C. Wainwright 26th Annual Global Investment Conference. This important event will be held in New York, where the company plans to discuss its groundbreaking strategies for addressing neurodegenerative disorders.
Presentation Highlights
During the conference, Rick Barry, the Executive Chairman of Cassava, will participate in an engaging 'fireside chat' with Vernon T. Bernardino, PhD., who serves as the Managing Director of Biotechnology Equity Research at H.C. Wainwright. This discussion is expected to cover the latest advancements in the field and emphasize Cassava's significant contributions to the progress of Alzheimer’s treatment.
How to Join the Conference
Institutional investors who are registered can access the H.C. Wainwright conference website to schedule a meeting with the Cassava Sciences team. This opportunity allows for meaningful interactions and the chance to gain insights from key figures in the biotechnology industry.
Event Details
The conference is set for:
Date: Monday, September 9
Time: 3:00 PM to 3:30 PM Eastern Time
Webcast Information
About Cassava Sciences, Inc.
Cassava Sciences is committed to enhancing the understanding and treatment of neurodegenerative diseases, particularly focusing on Alzheimer's disease. With a robust research foundation, the company is developing innovative solutions aimed at regulating a crucial brain protein, which could significantly improve the lives of patients facing these challenging conditions.
Contact Information
For more information, Eric Schoen, the Chief Financial Officer of Cassava Sciences, can be contacted at (512) 501-2450 or via email at ESchoen@CassavaSciences.com. Eric is ready to address any questions regarding the company's projects and the upcoming conference presentation.
Frequently Asked Questions
What is the H.C. Wainwright Global Investment Conference?
The H.C. Wainwright Global Investment Conference is an annual gathering that brings together investors and companies from the biotechnology sector to exchange insights and explore investment opportunities.
Who will represent Cassava Sciences at the conference?
Rick Barry, the Executive Chairman of Cassava Sciences, will be the representative for the company at the conference.
How can I watch the Cassava Sciences presentation?
The presentation will be available through a live webcast on Cassava Sciences' “Investors” page, along with a replay option for those unable to attend live.
What is the focus of Cassava Sciences?
Cassava Sciences specializes in developing therapies for neurodegenerative diseases, with a particular emphasis on Alzheimer’s disease, by targeting essential proteins in the brain.
How can investors connect with Cassava Sciences during the conference?
Registered institutional investors can log into the H.C. Wainwright conference website to request meetings with representatives from Cassava Sciences.